Phosphorylation of ERalpha at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ERalpha phosphorylation in breast cancer progression.

导出 LinkOut

翻译打印收藏纠错

作者： N,Sarwar ^[1] ; J-S,Kim ; J,Jiang ; D,Peston ; H D,Sinnett ; P,Madden ; J M,Gee ; R I,Nicholson ; A E,Lykkesfeldt ; S,Shousha ; R C,Coombes ; S,Ali

作者单位： Department of Oncology, Imperial College London, Hammersmith Hospital Campus, UK. ^[1]

主题词乳腺肿瘤(Breast Neoplasms);疾病恶化(Disease Progression);抗药性, 肿瘤(Drug Resistance, Neoplasm);雌激素受体α(Estrogen Receptor alpha);女(雌)性(Female);人类(Humans);免疫组织化学(Immunohistochemistry);磷酰化(Phosphorylation);磷酸丝氨酸(Phosphoserine);预后(Prognosis);他莫昔芬(Tamoxifen);肿瘤细胞, 培养的(Tumor Cells, Cultured)

DOI 10.1677/erc.1.01123

PMID 16954434

发布时间 2015-11-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览9

Endocrine-related cancer

2006年13卷3期

851-61页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Phosphorylation of ERalpha at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ERalpha phosphorylation in breast cancer progression.

Endocrine-related cancer

相似文献

Endocrine-related cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Phosphorylation of ERalpha at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ERalpha phosphorylation in breast cancer progression.

Endocrine-related cancer

相似文献

Endocrine-related cancer

相关期刊

检索历史清除